68Ga-DOTATATE PET/CT用于转移性非典型脑膜瘤全身分期
一例43岁女性疑似复发WHO II级非典型脑膜瘤患者,68Ga-DOTATATE PET/CT显示颅内多发病灶高摄取,并可见骨、肺、肝多发阳性病灶,肺病灶活检证实为远隔转移。该病例提示68Ga-DOTATATE PET/CT对脑膜瘤全身分期具有高诊断价值,已知脑膜瘤患者出现远隔病灶时应将转移纳入鉴别诊断,并强调放射性配体治疗在转移性脑膜瘤中的意义。
要点
- 68Ga-DOTATATE PET/CT可显示脑膜瘤颅内及骨、肺、肝等远隔转移病灶。
- 已知脑膜瘤患者出现远隔病灶时,鉴别诊断应包括转移。
- 转移性脑膜瘤可考虑放射性配体治疗。
核心结论
- 68Ga-DOTATATE PET/CT对脑膜瘤全身分期具有高诊断价值,可发现脑和脊柱外的远隔转移。
研究设计与样本
- 个案报道:一例43岁女性疑似复发WHO II级非典型脑膜瘤患者接受68Ga-DOTATATE PET/CT检查。
主要发现
- 68Ga-DOTATATE PET/CT显示颅内广泛病灶高摄取,并见骨、肺、肝多发阳性病灶。
- 肺病灶活检证实为WHO II级非典型脑膜瘤远隔转移。
临床怎么用
- 已知脑膜瘤患者出现远隔病灶时,鉴别诊断应将转移纳入考虑。
- 转移性脑膜瘤患者可考虑放射性配体治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 43-year-old woman with suspected recurrence of atypical meningioma World Health Organization grade II presented extensive intracranial lesions with high Ga-DOTATATE uptake. Moreover, numerous Ga-DOTATATE-positive bone, lung, and liver lesions were seen. For final diagnosis, biopsies taken from a lung lesion revealed distant metastases of the atypical meningioma. This case underlines the high diagnostic power of Ga-DOTATATE PET/CT for the staging of meningioma even beyond cerebral or spinal lesions; in case of distant lesions in patients with known meningioma, differential diagnosis should also contain metastases despite their rare occurrence. Moreover, this case emphasizes radioligand therapy especially in metastatic meningioma.
引用
- Unterrainer M, Ilhan H, Vettermann F, et al. Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT. Clin Nucl Med. 2019. PMID: 30589668. doi:10.1097/RLU.0000000000002422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。